How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?

How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?

Abstract Objectives We conducted a multi-stakeholder survey to determine key areas where a joint European health technology assessment (HTA) could provide ‘additional benefit’ compared to the status quo of many parallel independent national and subnational assessments. Methods Leveraging three itera...

Full description

Bibliographic Details
Main Authors: Elaine Julian, Fabrizio Gianfrate, Oriol Sola-Morales, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande, Jörg Ruof
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Health Economics Review
Subjects:
EU HTA
Europe’s Beating Cancer Plan
Comparators
Endpoints
Clinical trial design
Real world evidence
Online Access:https://doi.org/10.1186/s13561-022-00379-7

Internet

https://doi.org/10.1186/s13561-022-00379-7

Similar Items